CJC-1295 without DAC is a synthetic peptide related to growth hormone-releasing hormone (GHRH) and is studied for its interaction with pathways involved in growth hormone regulation. Unlike the DAC-modified version, this form does not contain the Drug Affinity Complex modification, resulting in a different pharmacokinetic profile. It is primarily of interest to researchers investigating peptide signaling and endocrine pathways.